3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
4
Thoracic
1
Head & Neck
1
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
33
Pain, Postoperative
4
Chronic Pain
3
Neoplasms
2
Lymphoma, Non-Hodgkin
2
Lung Neoplasms
2
Breast Diseases
2
Brain Neoplasms
2
Agnosia
2
Vulvodynia
1
Uterine Cervical Neoplasms
1
Skin Diseases
1
Seroma
1
Recurrence
1
Radiation Injuries
1
Postoperative Hemorrhage
1
Peripheral Nervous System Diseases
1
Pathologic Complete Response
1
Ovarian Neoplasms
1
Neoplasms by Site
1
Mycosis Fungoides
1
Melanoma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, B-Cell, Marginal Zone
1
Hot Flashes
1
Hodgkin Disease
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Gangliosidosis, GM1
1
Gangliosidoses
1
Interventions
pembrolizumab
42
Paclitaxel
26
Cyclophosphamide
25
Carboplatin
23
olaparib
21
Nivolumab
16
fludarabine
15
Docetaxel
13
aldesleukin
12
Gemcitabine
11
Fulvestrant
11
veliparib
9
Bevacizumab
9
sargramostim
8
palbociclib
8
durvalumab
8
Trastuzumab
8
Magnetic Resonance Spectroscopy
8
liposomal doxorubicin
7
atezolizumab
7
Surveys and Questionnaires
7
Ipilimumab
7
Blood Specimen Collection
7
niraparib
6
avelumab
6
Taxes
6
Specimen Handling
6
Interleukin-2
6
Fluorouracil
6
Cisplatin
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Ovarian Neoplasms
×
Sodium Chloride
×
Breast
×
Clear all
NCT04237090
2020-10-12
PREMED-F1
Ciusss de L'Est de l'Île de Montréal
Phase 3
Completed
27 enrolled